Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-24-028274
Filing Date
2024-09-03
Accepted
2024-09-03 17:15:55
Documents
4
Period of Report
2024-10-24

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A mbrx20240228_pre14a.htm PRE 14A 581914
2 a01.jpg GRAPHIC 179877
3 a02.jpg GRAPHIC 122281
4 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-24-028274.txt   1009833
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37758 | Film No.: 241275043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)